BioSpace News Archive

Reflect Scientific, Inc., a provider of diverse products and services for the biotechnology, pharmaceutical, and transportation industries, announces a shareholder message from the CEO.

Galectin Therapeutics Inc., the leading developer of therapeutics that target galectin proteins, reported financial results and provided a business update for the quarter ended March 31, 2021.

Addex Therapeutics, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced that dipraglurant was able to rescue long-term impairment of synaptic plasticity in two well validated models of dystonia.

Eurofins Technologies continues to develop a range of diagnostic solutions for COVID-19, particularly in response to the threat of emerging mutations.

RELIEF THERAPEUTICS Holding AG, a biopharmaceutical company with its lead compound RLF-100TM in advanced clinical development to treat COVID-19-induced lung injury, is pleased to see the recent announcement by APR Applied Pharma Research S.A. regarding the initiation of a pivotal clinical trial with its novel nasal spray, temporarily codenamed APR-AOS2020, a Class III medical device, in patients with mild COVID-19.

Sanofi and GSK COVID-19 vaccine candidate demonstrates strong immune responses across all adultage groups in Phase 2 trial

GenSight Biologics, a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, announced the appointment of Françoise de Craecker to its Board of Directors, replacing Natalie Mount.

AR is expected to play a pivotal role in challenging applications in the field of image-guided therapy.

The demand within the global endodontic files market has been rising on account of advancements in the field of dentistry.

OraSure Technologies, Inc., a leader in point of care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, announced that Scott Gleason has been appointed Senior Vice President Investor Relations and Corporate Communications.